Business

Skydance and National Amusements near Paramount deal as special committee reviews terms

Products You May Like

In this article

Shari Redstone, president of National Amusements, speaks at the WSJ Tech Live conference in Laguna Beach, California, on Oct. 21, 2019.
Mike Blake | Reuters

David Ellison’s Skydance has reached a preliminary deal with Shari Redstone’s National Amusements to merge with Paramount, according to two people familiar with the matter, resurrecting a deal which failed just weeks earlier.

Controlling shareholder National Amusements has referred the deal to the Paramount special committee, according to people familiar with the matter. Paramount’s special committee is currently reviewing and voting on the deal, according to a person familiar with the matter. A spokesperson for Paramount declined to comment.

Paramount shares surged as much as 9% on the news.

The resurrected deal will see Redstone receive a reduced consideration of $1.75 billion, according to a person familiar with the matter. The other financial terms of the deal, which CNBC previously reported, will remain unchanged: Skydance will acquire roughly half of Paramount’s controlling shares at $15 per share, for $4.5 billion, and contribute $1.5 billion towards Paramount’s balance sheet.

Redstone killed the initial bid in June as it was near the finish line. One of Redstone’s reasons was feeling as though Skydance had retraded the deal by asking her to take hundreds of millions of dollars less than the previously agreed to payment, according to one of the people.

The winding deal process had already led to the departure of CEO Bob Bakish earlier this year, leaving in place a three-headed office of the CEO to run the company. Other interested bids included a joint effort from private equity firm Apollo and Sony, as well as a recent entreaty from Barry Diller, chairman of media conglomerate IAC as well as a former Paramount executive.

The preliminary agreement was first reported by The New York Times and the Wall Street Journal.

— CNBC’s Julia Boorstin contributed to this report.

Products You May Like

Articles You May Like

Salesforce surges on revenue beat, AI growth prospects – here’s our new price target for the stock
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Court rejects Boeing plea deal in deadly 737 Max crashes, citing concerns with Justice Department’s DEI policies
Market FOMO? We go to the charts for attractive purchase levels on 2 buy-rated stocks
Shares of American Eagle plunge 13% as company issues weak holiday guidance

Leave a Reply

Your email address will not be published. Required fields are marked *